Impactiviti Daily 083109

TODAY’S NEWS
AstraZeneca’s experimental drug may bring serious competition to Plavix – AstraZeneca’s new pill Brilinta for preventing heart attacks works better than Plavix, the world’s second biggest selling drug, without increasing the amount of life-threatening bleeding, researchers said on Sunday…more
B-I’s new drug Praxada poised to finally provide an alternative to warfarin – Patients at risk [...]

Read Full Post »

Impactiviti Daily 082809

TODAY’S NEWS
Takeda to move forward with new alogliptin study – Takeda Pharmaceutical Co says it is all set to start an additional clinical trial demanded by US regulators on alogliptin, its investigational type 2 diabetes drug. The Japanese drugmaker noted that the US Food and Drug Administration has agreed to the study design for a [...]

Read Full Post »

Impactiviti Daily 082709

Did you know you can get Impactiviti Daily (Top Pharma News) direct to your Inbox each morning? Just click here to subscribe!
TODAY’S NEWS
Lots on J&J today – Elimination of the comprehensive care business unit; warnings of allergic reactions to its HIV drug Intelence; FDA finger-wagging for “misleading” advertising of athlete’s foot cream; no further development [...]

Read Full Post »

Golden Rule, or Gold-in Rule?

What should be the foundation of a pharma company’s business ethics – the Golden Rule or the Gold-in Rule? That’s the subject of my guest post on the healthcare blog KevinMD. And, lest any think I have unbalanced views, here’s a counter-balancing thought (for the record).

Read Full Post »

Impactiviti Daily 082609

Did you know you can get Impactiviti Daily (Top Pharma News) direct to your Inbox each morning? Just click here to subscribe!
TODAY’S NEWS
Amylin to be led by former Novartis exec – Amylin Pharmaceuticals has taken another step forward in its long & storied history. The company has announced that former Novartis executive Paulo Costa will [...]

Read Full Post »

Impactiviti Daily 082409

Did you know you can get Impactiviti Daily (Top Pharma News) direct to your Inbox each morning? Just click here to subscribe!
TODAY’S NEWS
P&G’s drug unit to be snapped up, by… – Warner Chilcott Ltd, a specialty drug maker, is acquiring Procter & Gamble Co’s prescription drug business for about $3 billion, two sources familiar with [...]

Read Full Post »

Impactiviti Daily 082109

TODAY’S NEWS
Why Pharma wants Obamacare. Thought provoking analysis from Forbes.
I like the headline: No Non-sinister Deed goes Unpunished. An interesting story about lobbying, healthcare reform, and The Medicines Company.
Takeda re-acquires Actos marketing rights in Canada.
RECOMMENDED
Negotiations Training – For Reps, Account Managers, and even up to the C-Suite: Impactiviti’s partner network includes some great suppliers for [...]

Read Full Post »

ePharma Review: Novartis’ YouTube Channel

Novartis, following in the footsteps of several other pharmaceutical companies, has launched a YouTube channel. I think this is a good move for two main reasons:
1. Even if pharma can’t take full advantage of social elements (immediate dialogue, free commenting, etc.) it is very important to put toes in the water and begin experimenting [...]

Read Full Post »

Impactiviti Daily 082009

TODAY’S NEWS
Femara keeps breast cancer at bay better than tamoxifen – Novartis AG’s Femara prevented breast cancer from returning regardless of whether women took the drug for five years or switched to a less expensive, generic medication two years into the treatment, a study found. [...]

Read Full Post »

Impactiviti Daily 081909

NEWS
One of Eli Lilly’s patents on Gemzar invalidated; may shave off 3 years of exclusivity – the method of use patent for its cancer drug Gemzar was invalidated by a federal court in Michigan, the drugmaker said today…more
Merck’s Gardasil vaccine safe overall, though some questions about promotional practices – two researchers at Columbia College of [...]

Read Full Post »